Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas

Cancer

Volumn 101, Issue 10, 2004, Pages 2230-2238

  Hwang, Jessica P ^a   Lam, Tony P ^a   Cohen, Deborah S ^a   Donato, Michele L ^a   Geraci, Jane M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Health disparities; Hematopoietic stem cell transplants; Leukemia; Texas

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COMORBIDITY; FEMALE; HEALTH CARE DISTRIBUTION; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NEWBORN; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; LEUKEMIA; MALE; MEDICALLY UNINSURED; MIDDLE AGED; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 7644241261     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20628     Document Type: Article

References (44)

1. Mitchell I, Meehan KR, Kong J, Schulman KA. Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors. J Clin Oncol. 1997;15: 2644-2651.
2. Barrett AJ, Horowitz MM, Gale RP, et al. Marrow transplantation of acute lymphoblastic leukemia: factors affecting relapse and survival. Blood. 1989;74:862-871.
3. Cahn JY, Labopin M, Mandelli F, et al. Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant Group. Blood. 1995;85:575-579.
4. Klingemann HG, Storb R, Fefer A, et al. Bone marrow transplantation in patients aged 45 years and older. Blood. 1986; 67:770-776.
5. Lennard AL, Jackson GH. Science, medicine, and the future: stem cell transplantation. BMJ. 2000;321:433-437.
6. Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Number of bone marrow transplants. 1993-2000. Available from URL: http://hcup.ahrq.gov/HCUPnet. asp [accessed September 30, 2004].
7. Elixhauser A, Steiner CA. Healthcare Cost and Utilization Project research note. Hospital inpatient statistics, 1996. Rockville, MD: Agency for Health Care Research and Quality, 1999.
8. Elixhauser A, Klemstine K, Steiner C, Bierman AS. Procedures in U.S. hospitals, 1997. HCUP Fact Book No. 2. Rockville, MD: Agency for Health Care Research and Quality, 2001.
9. Wenneker M, Epstein A. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. JAMA. 1989;261:253-257.
10. Ramsey SD, Hillman AL, Pauly MV. The effects of health insurance on access to new medical technologies. Int J Technol Assess Health Care. 1997;13:357-367.
11. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642-2646.
12. Johnson PA, Lee TH, Cook EF, Rouan GW, Goldman L. Effect of race on the presentation and management of patients with acute chest pain. Ann Intern Med. 1993;118:593-601.
13. Collins TC, Clark JA, Petersen LA, Kressin NR. Racial differences in how patients perceive physician communication regarding cardiac testing. Med Care. 2002;40(1 Suppl):I27-I34.
14. Carlisle DM, Leake BD, Shapiro MF. Racial and ethnic disparities in the use of cardiovascular procedures: associations with type of health insurance. Am J Public Health. 1997;87:263-267.
15. Laouri M, Kravitz RL, French WJ, et al. Underuse of coronary revascularization procedures: applications of a clinical method. J Am Coll Cardiol. 1997;29:891-897.
16. Kuykendall DH, Johnson ML, Geraci JM. Expected source of payment and use of hospital services for coronary atherosclerosis. Med Care. 1995;33:715-728.
17. Ferguson JA, Tierney WM, Westmoreland GR, et al. Examination of racial differences in management of cardiovascular disease. J Am Coll Cardiol. 1997;30:1707-1713.
18. Hannan EL, van Ryn M, Burke J, et al. Access to coronary artery bypass surgery by race/ethnicity and gender among patients who are appropriate for surgery. Med Care. 1999; 37:68-77.
19. Carlisle DM, Leake BD, Shapiro MF. Racial and ethnic differences in the use of invasive cardiac procedures among cardiac patients in Los Angeles County, 1986 through 1988. Am J Public Health. 1995;85:352-356.
20. Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med. 2001; 135:352-366.
21. Held PJ, Pauly MV, Bovbjerg RR, Newmann J, Salvatierra O Jr. Access to kidney transplantation: has the United States eliminated income and racial differences? Arch Intern Med. 1988;148:2594-2600.
22. Kjellstrand CM. Age, sex, and race inequality in renal transplantation. Arch Intern Med. 1988;148:1305-1309.
23. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343:1537-1544.
24. Ozminkowski RJ, White AJ, Hassol A, Murphy M. Minimizing racial disparity regarding receipt of a cadaver kidney transplant. Am J Kidney Dis. 1997;30:749-759.
25. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998; 280:1148-1152.
26. Young CJ, Gaston RS. Medical progress: renal transplantation in black Americans. N Engl J Med. 2000;343:1545-1552.
27. Boulware LE, Ratner LE, Cooper LA, Sosa JA, LaVeist TA, Powe NR. Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care. 2002;40:85-95.
28. Kasiske BL, Neylan JF III, Riggio RR, et al. The effect of race on access and outcome in transplantation. N Engl J Med. 1991;324:302-307.
29. McCauley J, Irish W, Thompson L, et al. Factors determining the rate of referral, transplantation, and survival on dialysis in women with ESRD. Am J Kidney Dis. 1997;30:739-748.
30. Klassen AC, Hall AG, Saksvig B, Curbow B, Klassen DK. Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation. Am J Public Health. 2002;92:811-817.
31. Texas Health Care Information Council. User manual for Texas hospital inpatient discharge public use data file. Austin: Texas Health Care Information Council, 1999.
32. Elixhauser A, Steiner C, Harris R, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998; 36:8-27.
33. Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP. Therapy decisions in leukemia. Bone Marrow Transplant. 1992;9:5-10.
34. Menzin J, Lang K, Earle CC, Kerney D, Mallick R. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med. 2002;162:1597-1603.
35. Ringden O, Horowitz MM, Gale RP, et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA. 1993;270:57-60.
36. Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol. 1999;17:2811-2818.
37. Maziarz RT, Mauro MJ. Transplantation for chronic myelogenous leukemia: yes, no, maybe so...an Oregeon perspective. Bone Marrow Transplant. 2003;32:459-469.
38. Frey P, Stinson T, Siston A, et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant. 2002;30:741-748.
39. Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ. Co-morbidity data in outcomes research. Are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol. 2000;53: 343-349.
40. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care. 2002;40:675-685.
41. Iezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias. JAMA. 1992; 267:2197-2203.
42. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA. 2003;289:2709-2716.
43. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170-1175.
44. Mays VM, Ponce NA, Washington DL, Cochran SD. Classification of race and ethnicity: implications for public health. Annu Rev Public Health. 2003;24:83-110.